FitLife Brands, Inc. is classed by the SEC under Medicinal Chemicals & Botanical Products (industry code 2833), based in Omaha, NE. Its latest filed balance sheet (2025-12-31) shows total assets of $104 million (its filed statements).
Product businessMedicinal Chemicals & Botanical ProductsOmaha, NEfilings since 20069 of 9 filed
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a product business: prior from its industry code (SEC 2833, Medicinal Chemicals & Botanical Products); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 5.8 out of ten, 9 of 9 metrics filed: past 5.1 out of ten, present 5.8 out of ten, future 6.5 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 2.8 out of ten. 12 warning events since 2017; the latest 2022-10-18. 28th percentile among 20 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 8.1 out of ten. +27.3% a year over 7 filed years; profitable in 7 of 7. 81st percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 2.6 out of ten. Share count grew 26.1% a year. 0% of cash flow returned. Insiders: 0 sales, 4 purchases. 26th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Financial health (present): 6.6 out of ten. ROE 14%: 14¢ of profit per shareholder dollar. Leverage 59%: owes 59¢ per asset dollar. 66th percentile among 20 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 7.0 out of ten. top 30% of 18 in its family; net margin 7.8%. 70th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 2.1 out of ten. bottom 21% of 12 in its family for leadership. 21st percentile among 12 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 6.5 out of ten. top 35% of 18 in its family for room to expand. 65th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 8.9 out of ten. top 11% of 18 in its family for growth drivers. 89th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 2.7 out of ten. bottom 27% of 18 in its family for expectations against reality. 27th percentile among 18 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-03-31 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-13 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-13 for the period ended 2026-08-11 (on EDGAR). Newest filing: Form 8-K, 2026-09-09. Filings on record since 2006. Read from EDGAR 2026-10-12.
Where the revenue comes from
Lines of business in fiscal 2025: Legacy Fit Life 76%, Irwin 24%. By geography: United States 95%, Outside the United States 5%. As tagged in its annual report (Form 10-K, filed 2026-03-31).
Who runs it
Hansen, Ryan P. (President); York, Jakob (CHIEF FINANCIAL OFFICER); Pappas, Shannon K. (director); Yakatan, Seth (director); Dawson, Grant Robert (director); Lingenbrink, Matthew (director). 6 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.